Baxion
Screening
Tags
Alerts
Theme
Clearmind Medicine Inc.
CMND
·
NASDAQ
·
$2.59
Share Price as of 11/2
·
$3M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
20-F
Annual report (foreign)
01/20/26
20-F
Annual report (foreign)
01/22/25
20-F/A
Annual report (foreign, amended)
03/27/24
20-F/A
Annual report (foreign, amended)
03/18/24
20-F
Annual report (foreign)
01/29/24
Disclosures
Filter
6-K
Foreign issuer report
10/27/26
6-K
Foreign issuer report
10/16/26
6-K
Foreign issuer report
10/13/26
6-K
Foreign issuer report
10/08/26
6-K
Foreign issuer report
10/07/26
Prospectuses and Registrations
Filter
POS AM
Post-effective amendment
06/15/26
F-3
Shelf registration (foreign)
04/30/26
POS AM
Post-effective amendment
03/25/26
POS AM
Post-effective amendment
03/25/26
F-3
Shelf registration (foreign)
02/17/26
Proxies
Filter
No matching filings.
Ownership
Filter
SC 13G
Beneficial ownership
10/27/26
SC 13G/A
Beneficial ownership (amended)
08/12/26
Form 4
Insider transaction
06/18/26
Form 4
Insider transaction
06/17/26
Form 4
Insider transaction
06/16/26
Other
Filter
EFFECT
Request for effectiveness
06/18/26
EFFECT
Request for effectiveness
05/07/26
CORRESP
Correspondence with the SEC
05/06/26
UPLOAD
Letter from the SEC
05/06/26
EFFECT
Request for effectiveness
03/30/26
Latest Filings
Filter
6-K
Foreign issuer report
10/27/26
6-K
Foreign issuer report
10/16/26
6-K
Foreign issuer report
10/13/26
6-K
Foreign issuer report
10/08/26
6-K
Foreign issuer report
10/07/26
Ownership
Filter
SC 13G
Beneficial ownership
10/27/26
SC 13G/A
Beneficial ownership (amended)
08/12/26
Form 4
Insider transaction
06/18/26
Form 4
Insider transaction
06/17/26
Form 4
Insider transaction
06/16/26